XIX International AIDS Conference

A randomized multicentre open-label trial to estimate the efficacy and safety of two doses of raltegravir (RAL) to efavirenz (EFV) for the treatment of HIV-TB co-infected patients: results of the ANRS 12 180 Reflate TB trial THLBB01

Time: 16:30
Speaker: Nathalie De Castro

This text willreplaced

You can download the video file here

For more information on this presentation, including access to speaker presentations, please see the conference Programme-at-a-Glance page.

Contact Us | Site map © 2012 International AIDS Society